BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17391978)

  • 1. Defects in growth hormone receptor signaling.
    Rosenfeld RG; Belgorosky A; Camacho-Hubner C; Savage MO; Wit JM; Hwa V
    Trends Endocrinol Metab; 2007; 18(4):134-41. PubMed ID: 17391978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current issues on molecular diagnosis of GH signaling defects.
    Feigerlova E; Hwa V; Derr MA; Rosenfeld RG
    Endocr Dev; 2013; 24():118-27. PubMed ID: 23392100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-I receptor signal transduction and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK-STAT) pathway.
    Himpe E; Kooijman R
    Biofactors; 2009; 35(1):76-81. PubMed ID: 19319849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT5b deficiency: lessons from STAT5b gene mutations.
    Hwa V; Nadeau K; Wit JM; Rosenfeld RG
    Best Pract Res Clin Endocrinol Metab; 2011 Feb; 25(1):61-75. PubMed ID: 21396575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New molecular mechanisms of growth hormone insensitivity].
    Edouard T; Raynal P; Yart A; Conte-Auriol F; Salles JP; Tauber M
    Arch Pediatr; 2008 Feb; 15(2):179-88. PubMed ID: 18207712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor.
    Meyer S; Ipek M; Keth A; Minnemann T; von Mach MA; Weise A; Ittner JR; Nawroth PP; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Kann PH; ;
    Growth Horm IGF Res; 2007 Aug; 17(4):307-14. PubMed ID: 17462934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary growth hormone (GH) insensitivity and insulin-like growth factor deficiency caused by novel compound heterozygous mutations of the GH receptor gene: genetic and functional studies of simple and compound heterozygous states.
    Fang P; Riedl S; Amselem S; Pratt KL; Little BM; Haeusler G; Hwa V; Frisch H; Rosenfeld RG
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2223-31. PubMed ID: 17405847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Src transduces signaling via growth hormone (GH)-activated GH receptor (GHR) tyrosine-phosphorylating GHR and STAT5 in human leukemia cells.
    Manabe N; Kubota Y; Kitanaka A; Ohnishi H; Taminato T; Tanaka T
    Leuk Res; 2006 Nov; 30(11):1391-8. PubMed ID: 16650892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone insensitivity resulting from post-GH receptor defects.
    Rosenfeld RG; Kofoed E; Little B; Woods K; Buckway C; Pratt K; Hwa V
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S35-8. PubMed ID: 15135774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatio-temporal kinetics of growth hormone receptor signaling in single cells using FRET microscopy.
    Biener-Ramanujan E; Ramanujan VK; Herman B; Gertler A
    Growth Horm IGF Res; 2006 Aug; 16(4):247-57. PubMed ID: 16950496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hwanggeumchal sorghum extract enhances BMP7 and GH signaling through the activation of Jak2/STAT5B in MC3T3‑E1 osteoblastic cells.
    Joung YH; Lim EJ; Darvin P; Jang JW; Park KD; Lee HK; Kim HS; Cho BW; Park T; Chung S; Park JH; Yang YM
    Mol Med Rep; 2013 Sep; 8(3):891-6. PubMed ID: 23877734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The growth hormone receptor (GHR) c.899dupC mutation functions as a dominant negative: insights into the pathophysiology of intracellular GHR defects.
    Derr MA; Aisenberg J; Fang P; Tenenbaum-Rakover Y; Rosenfeld RG; Hwa V
    J Clin Endocrinol Metab; 2011 Nov; 96(11):E1896-904. PubMed ID: 21900382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone (GH) insensitivity syndrome due to a GH receptor truncated after Box1, resulting in isolated failure of STAT 5 signal transduction.
    Milward A; Metherell L; Maamra M; Barahona MJ; Wilkinson IR; Camacho-Hübner C; Savage MO; Bidlingmaier M; Clark AJ; Ross RJ; Webb SM
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1259-66. PubMed ID: 15001620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D3 cannot revert desensitization of growth hormone (GH)-induced STAT5-signaling in GH-overexpressing mice non-calcemic tissues.
    Sotelo AI; Miquet JG; González L; Bartke A; Turyn D
    Growth Horm IGF Res; 2008 Apr; 18(2):148-56. PubMed ID: 17881271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone insensitivity and severe short stature in siblings: a novel mutation at the exon 13-intron 13 junction of the STAT5b gene.
    Hwa V; Camacho-Hübner C; Little BM; David A; Metherell LA; El-Khatib N; Savage MO; Rosenfeld RG
    Horm Res; 2007; 68(5):218-24. PubMed ID: 17389811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human growth disorders associated with impaired GH action: Defects in STAT5B and JAK2.
    Hwa V
    Mol Cell Endocrinol; 2021 Jan; 519():111063. PubMed ID: 33122102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and biochemical characteristics of a male patient with a novel homozygous STAT5b mutation.
    Vidarsdottir S; Walenkamp MJ; Pereira AM; Karperien M; van Doorn J; van Duyvenvoorde HA; White S; Breuning MH; Roelfsema F; Kruithof MF; van Dissel J; Janssen R; Wit JM; Romijn JA
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3482-5. PubMed ID: 16787985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mutant signal transducer and activator of transcription 5b, associated with growth hormone insensitivity and insulin-like growth factor-I deficiency, cannot function as a signal transducer or transcription factor.
    Fang P; Kofoed EM; Little BM; Wang X; Ross RJ; Frank SJ; Hwa V; Rosenfeld RG
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1526-34. PubMed ID: 16464942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel Y332C missense mutation in the intracellular domain of the human growth hormone receptor does not alter STAT5b signaling: redundancy of GHR intracellular tyrosines involved in STAT5b signaling.
    Derr MA; Fang P; Sinha SK; Ten S; Hwa V; Rosenfeld RG
    Horm Res Paediatr; 2011; 75(3):187-99. PubMed ID: 20962506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of immunodeficiency in a patient with growth hormone insensitivity secondary to a novel STAT5b gene mutation.
    Bernasconi A; Marino R; Ribas A; Rossi J; Ciaccio M; Oleastro M; Ornani A; Paz R; Rivarola MA; Zelazko M; Belgorosky A
    Pediatrics; 2006 Nov; 118(5):e1584-92. PubMed ID: 17030597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.